Bioceres Crop Solutions (BIOX) Debt to Equity (2017 - 2026)

Bioceres Crop Solutions has disclosed Debt to Equity across 10 years of filings, most recently posting $0.8 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.8, up 225.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.8 (up 225.62% YoY), and the FY2025 annual result was $0.62, up 20.98% from the prior year.
• Debt to Equity came in at $0.8 for Q1 2026 at Bioceres Crop Solutions, up from $0.62 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $1.03 in Q1 2022 to a low of $0.0 in Q3 2022.
• The 5-year median for Debt to Equity is $0.49 (2024), against an average of $0.51.
• Peak annual rise in Debt to Equity reached 12464.43% in 2023, while the deepest fall reached 54.22% in 2023.
• Bioceres Crop Solutions' Debt to Equity stood at $0.56 in 2022, then plunged by 34.53% to $0.36 in 2023, then soared by 33.26% to $0.49 in 2024, then climbed by 26.82% to $0.62 in 2025, then grew by 29.78% to $0.8 in 2026.
• The last three Debt to Equity figures came in at $0.8 (Q1 2026), $0.62 (Q2 2025), and $0.25 (Q1 2025), per Business Quant data.